Cell line · CVCL_1700
SK-N-AS
Cancer cell line, Homo sapiens. Neuroblastoma. 84 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. SK-N-AS. Cell lines, record CVCL_1700. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1700
On this page
Cell line
As Cellosaurus gives it.
- Name
- SK-N-AS
- Accession
- CVCL_1700
- RRID
- RRID:CVCL_1700
- Synonyms
- SKN-AS, SKNAS
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 6Y
- Category
- Cancer cell line
- Diseases
- Neuroblastoma (NCIt C3270); Neuroblastoma (ORDO Orphanet_635)
- Derived from
- Bone marrow (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers84
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| RAS inhibition limits oncogenic signaling and tumorigenesis in neuroblastoma regardless of RAS mutational status | Sci Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| LGALS3BP is associated with selective cargo enrichment in neuroblastoma extracellular vesicles. | Front Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| PP2A Activation as a Senotherapeutic in Neuroblastoma. | Cancers (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Calu-3 cells as novel efficient cell culture system for Borna disease virus 1 (BoDV-1). | Virus Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Multi‑omics identification of MSI2 as a super-enhancer‑driven vulnerability in MYCN‑amplified neuroblastoma. | J Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| USP29-regulated noncanonical stabilization of the hypoxia-inducible factor-α in aggressive prostate cancer. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Sialic acid cis-ligand dynamics modulate Siglec-7 and -9 function and affect Siglec-7/9 co-blockade to potentiate natural killer cell anti-tumor activity. | Oncoimmunology | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Functional profiling of somatostatin receptors identifies somatostatin receptor subtype 2 as a vulnerability in Succinate Dehydrogenase SDHB-deficient pheochromocytomas and paragangliomas. | Mol Biomed | 2026 | Its Methods give the RRID and name the line | PubMed | |
| DNA-PKcs promotes therapy resistance and metastatic recurrence in neuroblastoma. | Cancer Lett | 2026 | Its Methods give the RRID and name the line | PubMed | |
| YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma Cells. | Cancers (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 84
See all 84 papersRelatives32
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | EDITGENE GPBAR1 Knockout SK-N-AS Cell Line | CVCL_F5EC | Cell lines | |
| Derived from it | EDITGENE SK-N-AS-CopGFP | CVCL_F6AP | Cell lines | |
| Derived from it | EDITGENE SK-N-AS-FLUC | CVCL_F5V7 | Cell lines | |
| Derived from it | SK-N-AS RET KO clone C17 | CVCL_C0QD | Cell lines | |
| Derived from it | SK-N-AS RET KO clone C19 | CVCL_C0QE | Cell lines | |
| Derived from it | SK-N-AS RET KO clone C2 | CVCL_C0QA | Cell lines | |
| Derived from it | SK-N-AS RET KO clone C5 | CVCL_C0QB | Cell lines | |
| Derived from it | SK-N-AS RET KO clone C9 | CVCL_C0QC | Cell lines | |
| Derived from it | SK-N-AS RET overexpressing clone C1 | CVCL_C0Q9 | Cell lines | |
| Derived from it | SK-N-AS THAP1 F81L clone 35 | CVCL_E5VC | Cell lines |
1 to 10 of 32
See all 32 relativesCell banks6
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1700
GET https://conductscience.org/api/cell-lines/v1/CVCL_1700/papers?page=2